Clarivate (CLVT) Wolfe FinTech Forum summary

Business overview and segment focus

• Provides intelligence solutions, workflow solutions, and tech-enabled services for innovation-driven institutions and companies.

• Operates in three main end markets: Academia & Government, Intellectual Property, and Life Sciences & Healthcare.

• Intelligence solutions account for over half of offerings, with workflow and tech-enabled services supporting core markets.

Financial performance and guidance

• Saw an inflection point in 2025, with ACV growth improving from below 1% to nearly 2%.

• Organic recurring revenue growth expected to accelerate from 0.5% to 1–2% in 2026.

• Delivered over $1B adjusted EBITDA in 2025, with 200 basis points of margin expansion expected by 2026.

• Free cash flow projected to rise from $365M to $400M, driven by lower costs and capital spending.

Strategic review and portfolio optimization

• Initiated a strategic review to identify segments for divestiture to accelerate shareholder value.

• Announced pursuit of Life Sciences segment sale to focus on higher-margin A&G and IP segments and accelerate deleveraging.

• Proceeds from the sale expected to strengthen the balance sheet and reduce debt.